Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma-Reference-Cited by-同舟云学术

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Published:2022-06 Issue: Volume:20 Page:101413
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Chu Tan-Huy^ORCID,Vo Manh-Cuong^ORCID,Lakshmi Thangaraj Jaya^ORCID,Ahn Seo-Yeon,Kim Mihee,Song Ga-Young,Yang Deok-Hwan,Ahn Jae-Sook,Kim Hyeoung-Joon,Jung Sung-Hoon,Lee Je-Jung

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Multiple myeloma;Palumbo;N. Engl. J. Med.,2011

3. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma;Chu;Cancer Immunol. Immunother.,2020

4. Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma;Dimopoulos;N. Engl. J. Med.,2016

5. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma;Raje;N. Engl. J. Med.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01

2. IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside;International Immunopharmacology;2024-05

3. Prognostic marker CD27 and its micro-environmental in multiple myeloma;BMC Cancer;2024-03-19

4. Modern Methods of Obtaining Immune Dendritic Cells With Anti-Tumor Potential;Innovative Biosystems and Bioengineering;2024-03-18

5. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03